<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Lynne L Levitsky, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Madhusmita Misra, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph I Wolfsdorf, MD, BCh
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alison G Hoppin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 31, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Type 1 diabetes mellitus (T1DM), one of the most common chronic diseases in childhood, is caused by insulin deficiency resulting from the destruction of insulin-producing pancreatic beta cells. (See
         <a class="medical medical_review" href="/z/d/html/1800.html" rel="external">
          "Pathogenesis of type 1 diabetes mellitus"
         </a>
         .)
        </p>
        <p>
         Children and adolescents with T1DM are at increased risk for developing other autoimmune diseases, most commonly autoimmune thyroiditis and celiac disease. One study from the United Kingdom reported that almost one-quarter of patients with T1DM younger than 21 years old have one or more other organ-specific antibodies [
         <a href="#rid1">
          1
         </a>
         ]. As with autoimmunity in general, females are at greater risk for multiple autoantibodies. These associated autoimmune diseases are presented here.
        </p>
        <p>
         Other issues in this population are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5816.html" rel="external">
          "Epidemiology, presentation, and diagnosis of type 1 diabetes mellitus in children and adolescents"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5817.html" rel="external">
          "Overview of the management of type 1 diabetes mellitus in children and adolescents"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/97229.html" rel="external">
          "Hypoglycemia in children and adolescents with type 1 diabetes mellitus"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5818.html" rel="external">
          "Complications and screening in children and adolescents with type 1 diabetes mellitus"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5808.html" rel="external">
          "Diabetic ketoacidosis in children: Treatment and complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          ROLE OF HUMAN LEUKOCYTE ANTIGEN GENOTYPE
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, associated endocrinopathies are more common in patients with T1DM expressing human leukocyte antigen (HLA)-DR3. However, HLA genotyping is not performed in a clinical setting to determine the risk of future endocrinopathies. Instead, clinical care includes screening protocols for the more common endocrinopathies associated with T1DM.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          AUTOIMMUNE THYROIDITIS
         </span>
        </p>
        <p class="headingAnchor" id="H1706057809">
         <span class="h2">
          Epidemiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with T1DM are predisposed to the following thyroid conditions:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Positive
         </strong>
         <strong>
          antithyroid antibodies
         </strong>
         – Up to 25 percent have positive antithyroid antibodies (antithyroid peroxidase [TPO-Ab] and/or antithyroglobulin [Tg-Ab]) [
         <a href="#rid2">
          2-7
         </a>
         ]. The prevalence is higher in females than males and increases with age and diabetes duration [
         <a href="#rid4">
          4,8,9
         </a>
         ]. In one study, 15 percent of children with T1DM had antithyroid antibodies: TPO-Ab were found in 19.9 percent of girls and 11.6 percent of boys, and Tg-Ab were found in 18.6 of girls and 11 percent of boys [
         <a href="#rid4">
          4
         </a>
         ]. Patients with antithyroid antibodies may remain euthyroid or develop compensated or overt hypothyroidism.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Children with antibodies to glutamic acid decarboxylase and zinc-transporter 8 appear to have a higher risk of developing antithyroid antibodies [
         <a href="#rid1">
          1,8-12
         </a>
         ]. Specific human leukocyte antigen (HLA) subtypes (eg, HLA-DQB1*0302) have also been associated with greater risk of developing autoimmune thyroid disease [
         <a href="#rid3">
          3,13
         </a>
         ]. One study reported that DR3-DQ2/DRB1*04:01-DQ8 is a susceptibility genotype for T1DM with autoimmune thyroiditis, while the DRB1*11:01-DQA1*05:05-DQB1*03:01 and DRB1*15:01-DQA1*01:02-DQB1*06:02 genotypes are protective [
         <a href="#rid14">
          14
         </a>
         ]. DQB1*05:01 may also be protective [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypothyroidism
         </strong>
         – Autoimmune hypothyroidism develops before adulthood in up to 10 percent [
         <a href="#rid4">
          4,15-17
         </a>
         ]. As an example, in one study, 9.4 percent of a pediatric cohort (or 61 percent of those with antithyroid antibodies) developed hypothyroidism after a median diabetes duration of 3.4 years [
         <a href="#rid4">
          4
         </a>
         ]. Hypothyroidism is less common before adolescence; in a registry study of children &lt;14 years, 3.2 percent had hypothyroidism and the highest rates were in females ≥10 years [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other patients have subclinical hypothyroidism, defined as normal serum free thyroxine (fT4) concentration with elevated thyroid-stimulating hormone (TSH). One report suggested that subclinical hypothyroidism in patients with T1DM might be associated with an increased risk of symptomatic hypoglycemia [
         <a href="#rid18">
          18
         </a>
         ] and reduced linear growth [
         <a href="#rid19">
          19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7883.html" rel="external">
          "Subclinical hypothyroidism in nonpregnant adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         <strong>
          Hyperthyroidism
         </strong>
         – Rarely, children with T1DM may be hyperthyroid, with a reported prevalence of approximately 0.2 to 1 percent, which is significantly higher than in the age-matched general population [
         <a href="#rid4">
          4,20,21
         </a>
         ]. These cases represent Graves disease (caused by TSH receptor-stimulating antibodies) or Hashimoto thyroiditis (ie, the thyrotoxic phase of chronic autoimmune thyroiditis) [
         <a href="#rid21">
          21
         </a>
         ]. Children with T1DM and hyperthyroidism are more likely to have a history of diabetic ketoacidosis, hypoglycemia, and high blood pressure [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5841.html" rel="external">
          "Clinical manifestations and diagnosis of Graves disease in children and adolescents", section on 'Destructive thyroiditis with thyrotoxic phase'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Thyroid surveillance
         </span>
         <span class="headingEndMark">
          —
         </span>
         All children with T1DM should have regular surveillance for thyroid disease by measuring TSH  (
         <a class="graphic graphic_table graphicRef97226" href="/z/d/graphic/97226.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid7">
          7,22
         </a>
         ]. Autoimmune thyroiditis is common in this population and can affect the clinical course. (See
         <a class="medical medical_review" href="/z/d/html/5838.html" rel="external">
          "Acquired hypothyroidism in childhood and adolescence"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          TSH
         </strong>
         – Measure TSH (thyrotropin), followed by fT4 (or T4) if TSH is abnormal ("reflexive" testing)  (
         <a class="graphic graphic_algorithm graphicRef138522" href="/z/d/graphic/138522.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Perform the first test soon after the diagnosis of T1DM, when the patient is clinically stable (ie, after glycemic control has been established) [
         <a href="#rid7">
          7,22
         </a>
         ]. Testing should be performed more promptly for children with signs or symptoms suggesting thyroid disease, such as thyroid enlargement or symptoms of hypo- or hyperthyroidism. At least 20 percent of patients have transient abnormalities of thyroid function when T1DM is first diagnosed, which resolve as diabetes is treated [
         <a href="#rid23">
          23,24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If TSH is normal, repeat the test every one to two years, or annually if TPO-Ab or Tg-Ab are positive. Repeat if the patient develops clinical symptoms that might be attributable to thyroid dysfunction, such as an abnormal growth rate or unexplained glycemic excursions, or if thyromegaly is detected [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antithyroid antibodies
         </strong>
         – We measure TPO-Ab and Tg-Ab at or soon after diagnosis, consistent with American and International guidelines [
         <a href="#rid7">
          7,22
         </a>
         ]. An alternative strategy is to measure these antibodies only if abnormalities of thyroid function are detected. In patients with autoimmune thyroid disease, TPO-Ab is more likely to be positive than is Tg-Ab [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If the initial antibody test is positive or if there is a family history of autoimmune thyroid disease, the patient should be monitored closely by measuring TSH annually and if any symptoms of hyper- or hypothyroidism develop. Repeat antibody testing is not needed.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H780457290">
         <span class="h2">
          Diagnosis and next steps
         </span>
         <span class="headingEndMark">
          —
         </span>
         Abnormal screening results fall into one of the following categories:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypothyroidism
         </strong>
         – If TSH is elevated with low fT4 (or T4), treat with thyroid hormone replacement therapy. The presence of TPO-Ab and/or Tg-Ab confirms an autoimmune etiology. Patients with hypothyroidism and negative TPO-Ab and Tg-Ab require further evaluation to determine the cause. (See
         <a class="medical medical_review" href="/z/d/html/5838.html" rel="external">
          "Acquired hypothyroidism in childhood and adolescence", section on 'Treatment and prognosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Subclinical hypothyroidism
         </strong>
         – If TSH is elevated with normal fT4 (or T4), repeat the test within a few weeks before making a treatment decision. In addition, measure antithyroid antibodies (TPO-Ab and Tg-Ab), if they were previously negative or not already done. Patients with positive antithyroid antibodies are at risk of developing overt hypothyroidism over time.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Treatment decisions depend on the degree of TSH elevation. For those with TSH persistently &gt;10 mU/L, there is general agreement to treat, based on expert opinion. (See
         <a class="medical medical_review" href="/z/d/html/5838.html" rel="external">
          "Acquired hypothyroidism in childhood and adolescence", section on 'Indications for levothyroxine'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hyperthyroidism
         </strong>
         – If TSH is low (suppressed) with elevated fT4, the patient has hyperthyroidism. Further evaluation is warranted to determine the cause (ie, Graves disease versus thyrotoxic phase of autoimmune thyroiditis [Hashimoto thyroiditis]). (See
         <a class="medical medical_review" href="/z/d/html/5841.html" rel="external">
          "Clinical manifestations and diagnosis of Graves disease in children and adolescents", section on 'Diagnostic evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          CELIAC DISEASE
         </span>
        </p>
        <p class="headingAnchor" id="H893475269">
         <span class="h2">
          Epidemiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 5 to 10 percent of patients with T1DM have serologic evidence of celiac disease (anti-endomysial antibodies or tissue transglutaminase [tTG] antibodies) [
         <a href="#rid6">
          6,26,27
         </a>
         ], and approximately 5 percent have celiac disease confirmed by small bowel biopsy [
         <a href="#rid28">
          28-31
         </a>
         ]. Most cases of celiac disease (up to 79 percent in one study) are diagnosed within five years of diabetes onset [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
         These prevalence rates appear to be the same in the United States, Europe, Canada, and Asia, although one study from Sweden has reported a higher prevalence rate of 9 percent [
         <a href="#rid32">
          32
         </a>
         ]. In the Swedish study, 62 percent of those diagnosed with celiac disease following onset of T1DM had positive celiac-specific antibodies within 24 months of diagnosis of T1DM. One study also reported a higher five-year cumulative incidence of celiac disease in Finland compared with neighboring Estonia (0.77 versus 0.27 percent) [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
         Risk factors for celiac disease include female sex, younger age of onset and longer duration of T1DM, and presence of thyroid disease [
         <a href="#rid6">
          6,34-36
         </a>
         ]. The study cited above suggests that early life sequential infections may increase the risk of celiac disease [
         <a href="#rid33">
          33
         </a>
         ]. The genetic susceptibility to celiac disease and T1DM has been attributed to specific shared alleles [
         <a href="#rid37">
          37
         </a>
         ]. The human leukocyte antigen (HLA)-DR3-DQ2 and DR4-DQ8 haplotypes are associated with increased risk for these disorders [
         <a href="#rid1">
          1
         </a>
         ], whereas the DQB1*06:02 and DRB1*04 alleles are protective [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3404774626">
         <span class="h2">
          Clinical manifestations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Only a minority of children with T1DM and celiac disease present with gastrointestinal symptoms of food intolerance, food avoidance, gastrointestinal discomfort, and diarrhea. More common initial findings include unpredictable blood glucose measurements, recurrent episodes of hypoglycemia, poor glycemic control, and growth failure because of erratic intestinal absorption of nutrients [
         <a href="#rid40">
          40-45
         </a>
         ]. In addition, bone mineralization may be reduced [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Celiac surveillance
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because of the prevalence of celiac disease and its potential clinical impact on patients with T1DM, all children with T1DM should have regular surveillance for celiac disease  (
         <a class="graphic graphic_table graphicRef97226" href="/z/d/graphic/97226.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid7">
          7
         </a>
         ]. Serologic testing for celiac disease is valid only when the child is being exposed to dietary gluten; false negative results may occur if the test is performed while on a gluten-free diet. (See
         <a class="medical medical_review" href="/z/d/html/100553.html" rel="external">
          "Diagnosis of celiac disease in children", section on 'Patients already on a gluten-free diet'
         </a>
         .)
        </p>
        <p>
         Surveillance for and diagnosis of celiac disease in children with T1DM and other high-risk groups are summarized in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef101112" href="/z/d/graphic/101112.html" rel="external">
          algorithm 2
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Test for celiac disease by measuring tTG-immunoglobulin A antibodies (tTG-IgA) soon after the diagnosis of T1DM [
         <a href="#rid7">
          7
         </a>
         ]. Because these tests are based upon IgA antibodies, a quantitative serum IgA level should also be obtained during the screening process to ensure that levels are not falsely low due to IgA deficiency. In patients with IgA deficiency, screening may be performed by measuring immunoglobulin G (IgG)-deamidated gliadin peptides or tTG-IgG. (See
         <a class="medical medical_review" href="/z/d/html/100553.html" rel="external">
          "Diagnosis of celiac disease in children", section on 'Pretesting diet'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Testing for HLA DQ2/DQ8 to determine genetic susceptibility to celiac disease is not a useful method to screen for celiac disease in this population, because a majority of individuals with T1DM carry these risk alleles [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If the screening test is positive (tTG &gt;3 times the upper limit of normal), refer the patient to a gastroenterologist for further evaluation, which usually includes a small bowel biopsy. (See
         <a class="medical medical_review" href="/z/d/html/100553.html" rel="external">
          "Diagnosis of celiac disease in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If the screening test is negative, patients should be rescreened for celiac disease within two years of diagnosis and then again after five years [
         <a href="#rid7">
          7,22
         </a>
         ]. More frequent screening and repeat screening after five years of diagnosis is appropriate for children who develop symptoms suggestive of celiac disease (gastrointestinal symptoms, poor growth, weight loss, or increased occurrence of hypoglycemia) or for those who have a first-degree relative with celiac disease. Repeated measurement of serum IgA levels is not necessary. (See
         <a class="medical medical_review" href="/z/d/html/5899.html" rel="external">
          "Epidemiology, pathogenesis, and clinical manifestations of celiac disease in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2322081981">
         <span class="h2">
          Management
         </span>
         <span class="headingEndMark">
          —
         </span>
         If the further evaluation confirms the diagnosis of celiac disease, management is with a gluten-free diet. Nutritional counseling should be provided by a registered dietitian who has experience in caring for patients with both diabetes and celiac disease. Because gluten-free dietary substitutes are often high in carbohydrate content, identifying gluten-free products with acceptable carbohydrate content is essential for successful management of these patients. (See
         <a class="medical medical_review" href="/z/d/html/5907.html" rel="external">
          "Management of celiac disease in children"
         </a>
         .)
        </p>
        <p>
         Some asymptomatic children and their families will reject a gluten-free diet. In this case, it is particularly important to monitor symptoms, 25-hydroxyvitamin D levels, and adequate bone mineralization.
        </p>
        <p class="headingAnchor" id="H3259394386">
         <span class="h2">
          Benefits and risks of treatment
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General benefits
         </strong>
         – The main benefits of treatment are to reduce symptoms, optimize growth (for those with impaired growth), and reduce long-term adverse health risks associated with celiac disease. These benefits are similar to patients with celiac disease but without T1DM. Although a gluten-free diet is an additional burden, one study reported that the development of celiac disease in children with T1DM had minimal impact on quality of life [
         <a href="#rid48">
          48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5907.html" rel="external">
          "Management of celiac disease in children", section on 'Rationale for strict gluten avoidance'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Glycemic control
         </strong>
         – Whether a gluten-free diet improves glycemic control in patients who have diabetes and celiac disease is unclear. Only a few small studies have investigated the effect of a strict gluten-free diet on patients with T1DM and silent celiac disease [
         <a href="#rid49">
          49-51
         </a>
         ]. Some studies have shown that a gluten-free diet was associated with a trend toward an increased body mass index and improved bone health, without any change in insulin requirements [
         <a href="#rid49">
          49,50
         </a>
         ]. Other studies have reported a reduction in severe hypoglycemic episodes but unchanged hemoglobin A1c levels and an increased insulin requirement [
         <a href="#rid52">
          52
         </a>
         ], reported increased postprandial glycemic excursions [
         <a href="#rid27">
          27,53
         </a>
         ], or reported no significant changes [
         <a href="#rid54">
          54
         </a>
         ]. In one small study, a gluten-free diet did not seem to alter risks for chronic complications of diabetes during adulthood [
         <a href="#rid55">
          55
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4774.html" rel="external">
          "Epidemiology, pathogenesis, and clinical manifestations of celiac disease in adults", section on 'Autoimmune disease'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Disordered eating
         </strong>
         – A threefold higher risk of disordered eating behavior has been reported in patients with T1DM and celiac disease compared with those with T1DM alone or celiac disease alone, particularly when the patient is older, female, or overweight [
         <a href="#rid56">
          56
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5818.html" rel="external">
          "Complications and screening in children and adolescents with type 1 diabetes mellitus", section on 'Eating disorders'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nutrition quality
         </strong>
         – Some have reported an imbalance in macronutrients in patients on a gluten-free diet [
         <a href="#rid57">
          57
         </a>
         ], while others have reported unchanged folate and hemoglobin levels. High-density lipoprotein cholesterol levels are lower in children with T1DM and celiac disease at diagnosis than in those without celiac disease and increase following implementation of the gluten-free diet [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          OTHER AUTOIMMUNE DISORDERS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other autoimmune disorders that are associated with T1DM but are uncommon include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Primary adrenal insufficiency (Addison disease)
         </strong>
         – Less than 1 percent of children with T1DM have autoimmune adrenalitis, which is characterized by low cortisol and aldosterone levels, high adrenocorticotropic hormone (ACTH), and positive 21-hydroxylase antibodies. In one report, approximately 2 percent of children with type 1 disease had circulating antibodies to steroid 21-hydroxylase [
         <a href="#rid59">
          59
         </a>
         ]. This condition is associated with decreased insulin requirement and increased frequency of hypoglycemia. (See
         <a class="medical medical_review" href="/z/d/html/169.html" rel="external">
          "Pathogenesis of autoimmune adrenal insufficiency", section on 'Humoral immunity'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Autoimmune polyglandular syndrome type 2 (APS 2)
         </strong>
         – Autoimmune adrenal insufficiency is present with other autoimmune endocrine disorders in APS 1 and 2  (
         <a class="graphic graphic_table graphicRef67520" href="/z/d/graphic/67520.html" rel="external">
          table 2
         </a>
         ). Although T1DM can be seen in either syndrome, it is more commonly seen as a component of APS 2. The DR3-DQ2/DRB1*04:04-DQ8 genotype has been associated with APS 2 [
         <a href="#rid14">
          14
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/166.html" rel="external">
          "Causes of primary adrenal insufficiency (Addison disease)", section on 'Autoimmune adrenalitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          IPEX
         </strong>
         – This syndrome of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) is characterized by severe immune deficiency, with endocrinopathy and enteropathy. It is caused by mutations in the
         <em>
          FOXP3
         </em>
         gene, leading to abnormal T regulatory cell function. The condition commonly manifests in the first few months of life and is characterized by diarrhea, dermatitis, and T1DM. IPEX-like syndromes have also been identified related to loss-of-function mutations in the
         <em>
          CD25
         </em>
         ,
         <em>
          STAT5b
         </em>
         , and
         <em>
          ITCH
         </em>
         genes and gain-of-function mutations in the
         <em>
          STAT1
         </em>
         gene [
         <a href="#rid60">
          60
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3924.html" rel="external">
          "IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Autoimmune gastritis
         </strong>
         – A higher risk of autoimmune gastritis has been reported in T1DM, characterized by antibodies that target the gastric H
         <sup>
          +
         </sup>
         /K
         <sup>
          +
         </sup>
         -ATPase (ATPA) pump [
         <a href="#rid1">
          1
         </a>
         ]. This disorder is associated with DR3-DQ2, DRB1*0404 (in males), and DR3-DQ2/DR4-DQ8 genotype.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3159937787">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111575.html" rel="external">
          "Society guideline links: Diabetes mellitus in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Autoimmune thyroiditis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Prevalence
         </strong>
         <strong>
          and clinical forms
         </strong>
         – Children and adolescents with type 1 diabetes mellitus (T1DM) have increased risks for each of the following manifestations of autoimmune thyroid disease compared with the general population (see
         <a class="local">
          'Epidemiology'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Antithyroid antibodies
         </strong>
         – Antithyroid antibodies are present in up to 25 percent. The prevalence is higher in females than males and increases with age and diabetes duration. These patients may remain euthyroid or they may develop subclinical (compensated) or overt hypothyroidism (or, less commonly, hyperthyroidism).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Hypothyroidism
         </strong>
         – Clinical autoimmune hypothyroidism develops in up to 10 percent before adulthood. Overt hypothyroidism is diagnosed based on elevated thyroid-stimulating hormone (TSH) and low total or free thyroxine (fT4). Other patients have subclinical (or compensated) hypothyroidism (elevated TSH and normal total or fT4).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Hyperthyroidism
         </strong>
         – Develops in up to 1 percent; this is usually caused by Graves disease or, occasionally, by Hashimoto thyroiditis (thyrotoxic phase of autoimmune thyroiditis).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Surveillance
         </strong>
         – For all children and adolescents with T1DM, routine surveillance for autoimmune thyroiditis consists of measuring TSH, with reflexive testing for fT4 (or total T4) if TSH is abnormal. The first test should be performed after metabolic control has been established, usually several weeks after the diagnosis of T1DM  (
         <a class="graphic graphic_algorithm graphicRef138522" href="/z/d/graphic/138522.html" rel="external">
          algorithm 1
         </a>
         ). In addition, we measure antithyroid antibodies (antithyroid peroxidase [TPO-Ab] and antithyroglobulin [Tg-Ab]), soon after diagnosis. (See
         <a class="local">
          'Thyroid surveillance'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         If TSH is normal, repeat the test every one to two years or sooner if the patient has clinical symptoms or signs suggesting hypothyroidism or hyperthyroidism  (
         <a class="graphic graphic_table graphicRef97226" href="/z/d/graphic/97226.html" rel="external">
          table 1
         </a>
         ). If TPO-Ab and/or Tg-Ab are positive, they do not need to be repeated. If both are negative initially, they should be repeated if hypothyroidism develops.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Diagnosis and next steps
         </strong>
         – Patients with hypothyroidism or hyperthyroidism require further evaluation and treatment. Management of subclinical hypothyroidism depends upon the degree of TSH elevation. (See
         <a class="local">
          'Diagnosis and next steps'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Celiac disease
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Prevalence and clinical manifestations
         </strong>
         – Approximately 5 percent of patients with T1DM have celiac disease. These patients sometimes present with gastrointestinal symptoms but more commonly are asymptomatic or have episodes of hypoglycemia or poor growth. Untreated celiac disease is associated with gastrointestinal symptoms and growth delay in some patients, decreased bone mineral accrual, and other long-term health risks. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Screening
         </strong>
         – Surveillance for celiac disease begins with routine measurement of tissue transglutaminase-immunoglobulin A antibodies (tTG-IgA) soon after the diagnosis of T1DM. Patients with positive results should be referred to a gastroenterologist for further evaluation, which usually includes a small bowel biopsy, as outlined in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef101112" href="/z/d/graphic/101112.html" rel="external">
          algorithm 2
         </a>
         ). (See
         <a class="local">
          'Celiac surveillance'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         If the initial tTG-IgA test is negative, it should be repeated within two years after diagnosis of T1DM and again after five years or whenever the patient exhibits symptoms that suggest celiac disease  (
         <a class="graphic graphic_table graphicRef97226" href="/z/d/graphic/97226.html" rel="external">
          table 1
         </a>
         ). More frequent testing should be considered in those with a first-degree relative with celiac disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Management
         </strong>
         – If the child has celiac disease, nutritional counseling should be provided by a registered dietitian who has experience in caring for patients with both diabetes and celiac disease. Patients require special guidance to ensure that their diet is optimized for both diseases as well as surveillance and prevention of disordered eating patterns. (See
         <a class="local">
          'Management'
         </a>
         above and
         <a class="local">
          'Benefits and risks of treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Kozhakhmetova A, Wyatt RC, Caygill C, et al. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study. Clin Exp Immunol 2018; 192:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kordonouri O, Klinghammer A, Lang EB, et al. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care 2002; 25:1346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sumník Z, Drevínek P, Snajderová M, et al. HLA-DQ polymorphisms modify the risk of thyroid autoimmunity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2003; 16:851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kordonouri O, Hartmann R, Deiss D, et al. Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty. Arch Dis Child 2005; 90:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roldán MB, Alonso M, Barrio R. Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus. Diabetes Nutr Metab 1999; 12:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warncke K, Fröhlich-Reiterer EE, Thon A, et al. Polyendocrinopathy in children, adolescents, and young adults with type 1 diabetes: a multicenter analysis of 28,671 patients from the German/Austrian DPV-Wiss database. Diabetes Care 2010; 33:2010.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American Diabetes Association Professional Practice Committee. 14. Children and Adolescents: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022; 45:S208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karavanaki K, Kakleas K, Paschali E, et al. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM). Horm Res 2009; 71:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonifacio E, Mayr A, Knopff A, Ziegler AG. Endocrine autoimmunity in families with type 1 diabetes: frequent appearance of thyroid autoimmunity during late childhood and adolescence. Diabetologia 2009; 52:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kordonouri O, Charpentier N, Hartmann R. GADA positivity at onset of type 1 diabetes is a risk factor for the development of autoimmune thyroiditis. Pediatr Diabetes 2011; 12:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hwang GB, Yoon JS, Park KJ, et al. Prevalence of autoimmune thyroiditis in patients with type 1 diabetes: a long-term follow-up study. Ann Pediatr Endocrinol Metab 2018; 23:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jonsdottir B, Andersson C, Carlsson A, et al. Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents. Diabetologia 2013; 56:1735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katahira M, Maeda H, Tosaki T, Segawa S. The human leukocyte antigen class II gene has different contributions to autoimmune type 1 diabetes with or without autoimmune thyroid disease in the Japanese population. Diabetes Res Clin Pract 2009; 85:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flesch BK, Matheis N, Alt T, et al. HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III. J Clin Endocrinol Metab 2014; 99:E177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kordonouri O, Deiss D, Danne T, et al. Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes. Diabet Med 2002; 19:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spaans E, Schroor E, Groenier K, et al. Thyroid Disease and Type 1 Diabetes in Dutch Children: A Nationwide Study (Young Dudes-3). J Pediatr 2017; 187:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Severinski S, Banac S, Severinski NS, et al. Epidemiology and clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes. Coll Antropol 2009; 33:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohn A, Di Michele S, Di Luzio R, et al. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus. Diabet Med 2002; 19:70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chase HP, Garg SK, Cockerham RS, et al. Thyroid hormone replacement and growth of children with subclinical hypothyroidism and diabetes. Diabet Med 1990; 7:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leong KS, Wallymahmed M, Wilding J, MacFarlane I. Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes. Postgrad Med J 1999; 75:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dost A, Rohrer TR, Fröhlich-Reiterer E, et al. Hyperthyroidism in 276 Children and Adolescents with Type 1 Diabetes from Germany and Austria. Horm Res Paediatr 2015; 84:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fröhlich-Reiterer E, Elbarbary NS, Simmons K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes 2022; 23:1451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joseph J, Saroha V, Payne H, et al. Thyroid function at diagnosis of type I diabetes. Arch Dis Child 2011; 96:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilani BB, MacGillivray MH, Voorhess ML, et al. Thyroid hormone abnormalities at diagnosis of insulin-dependent diabetes mellitus in children. J Pediatr 1984; 105:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Triolo TM, Armstrong TK, McFann K, et al. Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care 2011; 34:1211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Puñales M, Bastos MD, Ramos ARL, et al. Prevalence of celiac disease in a large cohort of young patients with type 1 diabetes. Pediatr Diabetes 2019; 20:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahmud FH, Clarke ABM, Joachim KC, et al. Screening and Treatment Outcomes in Adults and Children With Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study. Diabetes Care 2020; 43:1553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aktay AN, Lee PC, Kumar V, et al. The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin. J Pediatr Gastroenterol Nutr 2001; 33:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crone J, Rami B, Huber WD, et al. Prevalence of celiac disease and follow-up of EMA in children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr 2003; 37:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pham-Short A, Donaghue KC, Ambler G, et al. Screening for Celiac Disease in Type 1 Diabetes: A Systematic Review. Pediatrics 2015; 136:e170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hughes JW, Riddlesworth TD, DiMeglio LA, et al. Autoimmune Diseases in Children and Adults With Type 1 Diabetes From the T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2016; 101:4931.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bybrant MC, Örtqvist E, Lantz S, Grahnquist L. High prevalence of celiac disease in Swedish children and adolescents with type 1 diabetes and the relation to the Swedish epidemic of celiac disease: a cohort study. Scand J Gastroenterol 2014; 49:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simre K, Uibo O, Peet A, et al. Exploring the risk factors for differences in the cumulative incidence of coeliac disease in two neighboring countries: the prospective DIABIMMUNE study. Dig Liver Dis 2016; 48:1296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cerutti F, Bruno G, Chiarelli F, et al. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Diabetes Care 2004; 27:1294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fröhlich-Reiterer EE, Hofer S, Kaspers S, et al. Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus--data from a German/Austrian multicentre survey. Pediatr Diabetes 2008; 9:546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fröhlich-Reiterer EE, Kaspers S, Hofer S, et al. Anthropometry, metabolic control, and follow-up in children and adolescents with type 1 diabetes mellitus and biopsy-proven celiac disease. J Pediatr 2011; 158:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359:2767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lernmark Å. Environmental factors in the etiology of type 1 diabetes, celiac disease, and narcolepsy. Pediatr Diabetes 2016; 17 Suppl 22:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deja G, Sikora D, Pyziak-Skupien A, et al. The Usefulness of Genotyping of Celiac Disease-Specific HLA among Children with Type 1 Diabetes in Various Clinical Situations. J Diabetes Res 2020; 2020:7869350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verkasalo M, Kuitunen P, Leisti S, Perheentupa J. Growth failure from symptomless celiac disease. A study of 14 patients. Helv Paediatr Acta 1978; 33:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashkenazi, A. Occult celiac disease: a common cause of short stature. Growth, Genetics and Hormones 1989; 5:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freemark M, Levitsky LL. Screening for celiac disease in children with type 1 diabetes: two views of the controversy. Diabetes Care 2003; 26:1932.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iafusco D, Rea F, Prisco F. Hypoglycemia and reduction of the insulin requirement as a sign of celiac disease in children with IDDM. Diabetes Care 1998; 21:1379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohn A, Cerruto M, Iafusco D, et al. Celiac disease in children and adolescents with type I diabetes: importance of hypoglycemia. J Pediatr Gastroenterol Nutr 2001; 32:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simmons JH, Foster NC, Riddlesworth TD, et al. Sex- and age-dependent effects of celiac disease on growth and weight gain in children with type 1 diabetes: Analysis of the type 1 diabetes Exchange Clinic Registry. Pediatr Diabetes 2018; 19:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simmons KM, McFann K, Taki I, et al. Reduced Bone Mineral Density Is Associated with Celiac Disease Autoimmunity in Children with Type 1 Diabetes. J Pediatr 2016; 169:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Binder E, Rohrer T, Denzer C, et al. Screening for coeliac disease in 1624 mainly asymptomatic children with type 1 diabetes: is genotyping for coeliac-specific human leucocyte antigen the right approach? Arch Dis Child 2019; 104:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sud S, Marcon M, Assor E, et al. Quality of life in children with diabetes and celiac disease: minimal impact of the 'double diagnosis'. Pediatr Diabetes 2012; 13:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Acerini CL, Ahmed ML, Ross KM, et al. Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet. Diabet Med 1998; 15:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westman E, Ambler GR, Royle M, et al. Children with coeliac disease and insulin dependent diabetes mellitus--growth, diabetes control and dietary intake. J Pediatr Endocrinol Metab 1999; 12:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simmons JH, Klingensmith GJ, McFann K, et al. Celiac autoimmunity in children with type 1 diabetes: a two-year follow-up. J Pediatr 2011; 158:276.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abid N, McGlone O, Cardwell C, et al. Clinical and metabolic effects of gluten free diet in children with type 1 diabetes and coeliac disease. Pediatr Diabetes 2011; 12:322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pham-Short A, Donaghue KC, Ambler G, et al. Greater postprandial glucose excursions and inadequate nutrient intake in youth with type 1 diabetes and celiac disease. Sci Rep 2017; 7:45286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taler I, Phillip M, Lebenthal Y, et al. Growth and metabolic control in patients with type 1 diabetes and celiac disease: a longitudinal observational case-control study. Pediatr Diabetes 2012; 13:597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Creanza A, Lupoli R, Lembo E, et al. Glycemic control and microvascular complications in adults with type 1 diabetes and long-lasting treated celiac disease: A case-control study. Diabetes Res Clin Pract 2018; 143:282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tokatly Latzer I, Rachmiel M, Zuckerman Levin N, et al. Increased prevalence of disordered eating in the dual diagnosis of type 1 diabetes mellitus and celiac disease. Pediatr Diabetes 2018; 19:749.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu A, Marcon M, Assor E, et al. Dietary Intake and Micronutrient Supplementation in Youth with Celiac Disease with and without Type 1 Diabetes. Can J Diet Pract Res 2018; 79:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salardi S, Maltoni G, Zucchini S, et al. Celiac Disease Negatively Influences Lipid Profiles in Young Children With Type 1 Diabetes: Effect of the Gluten-Free Diet. Diabetes Care 2016; 39:e119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peterson P, Salmi H, Hyöty H, et al. Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. Clin Immunol Immunopathol 1997; 82:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verbsky JW, Chatila TA. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. Curr Opin Pediatr 2013; 25:708.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5823 Version 28.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29431870" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12145233" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12948297" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : HLA-DQ polymorphisms modify the risk of thyroid autoimmunity in children with type 1 diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15781936" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10517303" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20551013" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Polyendocrinopathy in children, adolescents, and young adults with type 1 diabetes: a multicenter analysis of 28,671 patients from the German/Austrian DPV-Wiss database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34964865" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : 14. Children and Adolescents: Standards of Medical Care in Diabetes-2022.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19258711" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19018508" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Endocrine autoimmunity in families with type 1 diabetes: frequent appearance of thyroid autoimmunity during late childhood and adolescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20723098" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : GADA positivity at onset of type 1 diabetes is a risk factor for the development of autoimmune thyroiditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29609447" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Prevalence of autoimmune thyroiditis in patients with type 1 diabetes: a long-term follow-up study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23666211" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19581015" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The human leukocyte antigen class II gene has different contributions to autoimmune type 1 diabetes with or without autoimmune thyroid disease in the Japanese population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24187405" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12060066" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28583704" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Thyroid Disease and Type 1 Diabetes in Dutch Children: A Nationwide Study (Young Dudes-3).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19408637" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Epidemiology and clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11869306" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2140081" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Thyroid hormone replacement and growth of children with subclinical hypothyroidism and diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10646024" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26202175" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Hyperthyroidism in 276 Children and Adolescents with Type 1 Diabetes from Germany and Austria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36537532" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20576659" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Thyroid function at diagnosis of type I diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6431066" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Thyroid hormone abnormalities at diagnosis of insulin-dependent diabetes mellitus in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21430083" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30737863" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Prevalence of celiac disease in a large cohort of young patients with type 1 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32345653" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Screening and Treatment Outcomes in Adults and Children With Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11698764" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12827008" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Prevalence of celiac disease and follow-up of EMA in children and adolescents with type 1 diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26077482" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Screening for Celiac Disease in Type 1 Diabetes: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27676394" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Autoimmune Diseases in Children and Adults With Type 1 Diabetes From the T1D Exchange Clinic Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24164443" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : High prevalence of celiac disease in Swedish children and adolescents with type 1 diabetes and the relation to the Swedish epidemic of celiac disease: a cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27499360" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Exploring the risk factors for differences in the cumulative incidence of coeliac disease in two neighboring countries: the prospective DIABIMMUNE study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15161778" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18713134" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus--data from a German/Austrian multicentre survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21051047" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Anthropometry, metabolic control, and follow-up in children and adolescents with type 1 diabetes mellitus and biopsy-proven celiac disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19073967" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Shared and distinct genetic variants in type 1 diabetes and celiac disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27411439" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Environmental factors in the etiology of type 1 diabetes, celiac disease, and narcolepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32149153" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The Usefulness of Genotyping of Celiac Disease-Specific HLA among Children with Type 1 Diabetes in Various Clinical Situations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/216652" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Growth failure from symptomless celiac disease. A study of 14 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Occult celiac disease: a common cause of short stature
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12766138" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Screening for celiac disease in children with type 1 diabetes: two views of the controversy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9702462" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Hypoglycemia and reduction of the insulin requirement as a sign of celiac disease in children with IDDM.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11176322" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Celiac disease in children and adolescents with type I diabetes: importance of hypoglycemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29271067" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Sex- and age-dependent effects of celiac disease on growth and weight gain in children with type 1 diabetes: Analysis of the type 1 diabetes Exchange Clinic Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26561381" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Reduced Bone Mineral Density Is Associated with Celiac Disease Autoimmunity in Children with Type 1 Diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30327331" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Screening for coeliac disease in 1624 mainly asymptomatic children with type 1 diabetes: is genotyping for coeliac-specific human leucocyte antigen the right approach?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21672108" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Quality of life in children with diabetes and celiac disease: minimal impact of the 'double diagnosis'.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9472862" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10821223" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Children with coeliac disease and insulin dependent diabetes mellitus--growth, diabetes control and dietary intake.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20817171" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Celiac autoimmunity in children with type 1 diabetes: a two-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21615651" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Clinical and metabolic effects of gluten free diet in children with type 1 diabetes and coeliac disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28338063" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Greater postprandial glucose excursions and inadequate nutrient intake in youth with type 1 diabetes and celiac disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22564209" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Growth and metabolic control in patients with type 1 diabetes and celiac disease: a longitudinal observational case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30075178" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Glycemic control and microvascular complications in adults with type 1 diabetes and long-lasting treated celiac disease: A case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29493097" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Increased prevalence of disordered eating in the dual diagnosis of type 1 diabetes mellitus and celiac disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29893137" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Dietary Intake and Micronutrient Supplementation in Youth with Celiac Disease with and without Type 1 Diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27271186" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Celiac Disease Negatively Influences Lipid Profiles in Young Children With Type 1 Diabetes: Effect of the Gluten-Free Diet.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9000040" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24240290" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
